Importance of quality‐of‐life priorities and preferences surrounding treatment decision making in patients with cancer and oncology clinicians-Reference-Cited by-同舟云学术

Importance of quality‐of‐life priorities and preferences surrounding treatment decision making in patients with cancer and oncology clinicians

Published:2020-05-19 Issue:15 Volume:126 Page:3534-3541
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Williams Courtney P.¹^ORCID,Miller‐Sonet Ellen²,Nipp Ryan D.³^ORCID,Kamal Arif H.⁴,Love Susan⁵,Rocque Gabrielle B.¹^ORCID

Affiliation:

1. Department of Medicine Division of Hematology and Oncology University of Alabama at Birmingham Birmingham Alabama USA

2. CancerCare New York New York USA

3. Department of Medicine Division of Hematology and Oncology Massachusetts General Hospital Cancer Center and Harvard Medical School Boston Massachusetts USA

4. Department of Medicine Duke University Medical Center and Duke Cancer Institute Durham North Carolina USA

5. Dr. Susan Love Research Foundation Encino California USA

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.32961

Reference39 articles.

1. Implementing shared decision making in the NHS

2. Shared Decision Making for Treatment of Cancer: Challenges and Opportunities

3. Risk Factors for Hospitalization Due to Community-Acquired Sepsis – A Population-Based Case-Control Study

4. Patient-Centered Care and Preference-Sensitive Decision Making

5. Decision aids for people facing health treatment or screening decisions;Stacey D;Cochrane Database Syst Rev,2014

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patients’ considerations of time toxicity when assessing cancer treatments with marginal benefit;The Oncologist;2024-07-23

2. Patient Preferences Influencing Treatment Decision-Making in Early-Stage Breast Cancer in Germany, Italy, and Japan;Patient Preference and Adherence;2024-07

3. Neoadjuvant pembrolizumab plus chemotherapy/adjuvant pembrolizumab for early-stage triple-negative breast cancer: quality-of-life results from the randomized KEYNOTE-522 study;JNCI: Journal of the National Cancer Institute;2024-06-24

4. A randomized controlled trial of shared decision-making treatment planning process to enhance shared decision-making in patients with MBC;Breast Cancer Research and Treatment;2024-06-10

5. Preparing for Cancer: A Qualitative Study of Hispanic Patient and Caregiver Needs;Healthcare;2024-05-30